EUVIMEDEUVIMED entdecken
Open Access

Disrupting DDB2-DNA Interaction by Lapatinib Enhances Chemotherapy Sensitivity

Shih-Chao Hsu, Yu-Hao He, Yun-Ju Chen, Uyen Nguyen Phuong Le, Pei-Tong Liu, Thanh Kieu Huynh, Yi-Ling Chen, Ya-Ling Wei, Hsin-Chiao Chou, Wei-Chien Huang, Long-Bin Jeng

International Journal of Biological Sciences · 2025

DOI: 10.7150/ijbs.116148 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2025. Verfasst von Shih-Chao Hsu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Biomedical Sciences, China Medical University, Taichung, 404333, Taiwan. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Neoplasms, DNA-Binding Proteins, Lapatinib. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmNeoplasmsDNA-Binding ProteinsLapatinibDNA RepairGene Expression Regulation, NeoplasticUp-RegulationMolecular Dynamics SimulationTyrosine Kinase InhibitorsDNAProtein BindingProteolysisOrganoidsDrug SynergismDoxorubicinAntineoplastic Combined Chemotherapy ProtocolsCell Line, TumorDrug RepositioningHumansMaleFemale

Stichwörter der Autor:innen

DDB2chemosensitizationlapatinibnucleotide excision repairproteasomal degradation

Substanzen

DDB2 protein, humanDNA-Binding ProteinsLapatinibTyrosine Kinase InhibitorsDNADoxorubicin

Autor:innen und Institutionen

  • Graduate Institute of Biomedical Sciences, China Medical University, Taichung, 404333, Taiwan.
  • Department of Surgery, China Medical University Hospital, Taichung, 404327, Taiwan.
  • Center for Molecular Medicine, China Medical University Hospital, Taichung, 406040, Taiwan.
  • Cancer Biology and Precision Therapeutics Center, China Medical University, Taichung, 406040, Taiwan.
  • School of Medicine, I-Shou University, Kaohsiung, 824005, Taiwan.
  • Department of Medical Research and Department of Pharmacy, E-Da Hospital, Kaohsiung, 824005, Taiwan.

Zitieren

APA

Hsu, S. C., He, Y. H., Chen, Y. J., Le, U. N. P., Liu, P. T., Huynh, T. K., Chen, Y. L., Wei, Y. L., Chou, H. C., Huang, W. C., & Jeng, L. B. (2025). Disrupting DDB2-DNA Interaction by Lapatinib Enhances Chemotherapy Sensitivity. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.116148

Vancouver

Hsu SC, He YH, Chen YJ, Le UNP, Liu PT, Huynh TK, et al. Disrupting DDB2-DNA Interaction by Lapatinib Enhances Chemotherapy Sensitivity. International Journal of Biological Sciences. 2025. doi:10.7150/ijbs.116148

BibTeX
@article{Hsu2025,
  author = {Hsu, Shih-Chao and He, Yu-Hao and Chen, Yun-Ju and Le, Uyen Nguyen Phuong and Liu, Pei-Tong and Huynh, Thanh Kieu and Chen, Yi-Ling and Wei, Ya-Ling and Chou, Hsin-Chiao and Huang, Wei-Chien and Jeng, Long-Bin},
  title = {Disrupting DDB2-DNA Interaction by Lapatinib Enhances Chemotherapy Sensitivity},
  journal = {International Journal of Biological Sciences},
  year = {2025},
  doi = {10.7150/ijbs.116148}
}
Kostenlos starten →